Public Comments
New England CEPAC

PDF cover

Obeticholic Acid: Public Comments

Public comments received on ICER’s Draft Evidence Reports reviewing the comparative clinical effectiveness and value of obeticholic acid (Ocaliva, Intercept Pharmaceuticals, Inc.) for primary biliary cholangitis and nonalcoholic steatohepatitis.


View All Materials on this Topic or Go Back to View More Materials